Nature Medicine pre-submission review

Free readiness scan for Nature Medicine.

Where basic science becomes medicine: the bridge from bench to bedside

Upload your manuscript and see the first desk-rejection risks, journal-fit verdict, and top reviewer objections calibrated for Nature Medicine in about 60 seconds.

Impact factor

50.0

Acceptance rate

<8%

First decision

~30 days to first decision

Anthropic

Anthropic Privacy Partner

Zero-retention manuscript processing. Your manuscript is not used for training.

Start free preview

Get a fast submission-risk check

Upload the draft and get the first signal on readiness, reviewer risk, and what is most likely to block submission.

Leave this blank if you mainly want a fast risk check. Add it if you want the preview calibrated to a specific journal.

Upload manuscript

Before you upload

Not used for model training. Your manuscript stays out of training data.

Deleted after analysis. The AI scan is a one-time processing flow.

No human reads the manuscript unless you separately choose expert review.

You can inspect a real sample report before paying for anything. The free preview is the low-friction first step.

Add your email to continue.

Free manuscript scan · Full report $29 if you want it

What Nature Medicine editors screen for

The signals Nature Medicine rewards before the first reviewer

The readiness scan checks your manuscript against these first.

The translational bridge - mechanism plus human relevance

Pure basic science belongs in Cell or Nature. Pure clinical trials belong in NEJM or Lancet. Nature Medicine wants the connection: basic discovery validated in human data, or clinical observation explained by mechanistic insight. If your paper has only one side of this bridge, it belongs in a different journal. The classic Nature Medicine paper has a mechanistic story in model systems plus validation in patient samples plus either a therapeutic demonstration or a clear clinical implication.

Human data - the bar has risen dramatically

Mouse-only translational studies rarely reach peer review at Nature Medicine anymore. You need human samples, patient-derived organoids, clinical data, or a direct demonstration of human relevance. The 'but it will be relevant to humans' argument is not sufficient. Human samples are not an afterthought - they are now a requirement. Plan your study to include them from the beginning, or position the work for a different journal.

Therapeutic implications beyond 'could be druggable'

Understanding a disease mechanism is the starting point, not the finish line. Nature Medicine wants to see what you can do with the knowledge: a therapeutic proof of concept, a drug target validation, a biomarker for treatment selection, or a clinical intervention study. Papers that identify a mechanism and conclude with 'this suggests X could be a therapeutic target' without testing it face skepticism. Show the therapeutic angle, don't just assert it.

Common Nature Medicine rejection patterns

Named failure modes the scan looks for

These are patterns Nature Medicine editors flag in initial triage. The free preview surfaces when your manuscript shows them.

Pattern 1

Submitting mouse studies without human validation

Nature Medicine's editorial team explicitly states that mouse-only translational studies no longer meet their standard. At minimum, you need human samples - patient biopsies, organoids, primary cells, clinical data - demonstrating that the mechanism is present and relevant in humans. If you don't have human data yet, the paper belongs at a journal with a lower human-data bar while you generate the validation.

Pattern 2

Clinical data without mechanistic insight

A randomized controlled trial showing that treatment A works better than treatment B is a NEJM or Lancet paper. Nature Medicine wants to know why it works. If you have excellent clinical trial data but no mechanistic story, submit to the appropriate clinical journal. If you add a mechanistic substudy - even relatively small - that explains the mechanism, the paper may become appropriate for Nature Medicine.

Pattern 3

Handwaving about therapeutic potential

Papers that identify a disease mechanism and conclude with 'this pathway could be targeted therapeutically' without any therapeutic data are consistently flagged. Reviewers at Nature Medicine expect at least a proof-of-concept demonstration that the mechanism is actionable - a preclinical drug study, a genetic knockdown with phenotypic rescue, or a small cohort pharmacological intervention.

Common questions about Nature Medicine submissions

Does the scan understand Nature Medicine's editorial standards?

The readiness scan is calibrated to Nature Medicine's scope and review signals. It estimates desk-rejection risk against known triage patterns, flags where your manuscript sits against journal fit, and surfaces the specific reviewer objections most likely to come up.

How long does the Nature Medicine scan take?

The free preview takes about 60 seconds once you upload. If you want the full diagnostic with verified citations and section-by-section critique, it is delivered as a DOCX within 30 minutes.

Is my manuscript safe?

Yes. Uploads are encrypted in transit, not used to train any AI model, and deleted after analysis. No human reads your manuscript on the AI path.

Where can I read more about Nature Medicine?

See the full Nature Medicine submission guide for scope details, insider tips, and acceptance-rate context. Or see how the AI diagnostic works across all journals.

Find out before Nature Medicine's editors do

Your reviewers will find these issues. The question is whether you find them first. Free preview in 60 seconds.

Start the free Nature Medicine scan